5 results on '"Lucas, R."'
Search Results
2. Pseudomonas aeruginosa lasR mutants are associated with cystic fibrosis lung disease progression
- Author
-
Hoffman, Lucas R., Kulasekara, Hemantha D., Emerson, Julia, Houston, Laura S., Burns, Jane L., Ramsey, Bonnie W., and Miller, Samuel I.
- Subjects
- *
CYSTIC fibrosis , *PSEUDOMONAS aeruginosa infections , *GENETIC mutation , *AIRWAY (Anatomy) , *LUNG physiology , *REGRESSION analysis , *GENETICS , *DISEASES - Abstract
Abstract: Background: Pseudomonas aeruginosa with mutations in the transcriptional regulator LasR chronically infect the airways of people with cystic fibrosis (CF), yet the prevalence and clinical implications of lasR mutant infection are unknown. Methods: In an exploratory study, we screened 166 P. aeruginosa isolates from 58 CF patients for LasR inactivation and mucoidy, and compared clinical characteristics among source patients. Results: lasR mutation prevalence was comparable to that of mucoidy, the best-described CF-adapted phenotype, but affected patients were on average approximately 2 years younger. In a regression analysis, lung function decline with age was worse among patients with lasR mutant infection than in those without, similar to the effect of mucoidy. Conclusions: Culture positivity for lasR mutant P. aeruginosa may serve as a marker of early CF adaptive change of prognostic significance. Furthermore, as LasR inactivation alters susceptibility to antibiotics, infection with lasR mutant P. aeruginosa may impact response to therapy. [Copyright &y& Elsevier]
- Published
- 2009
- Full Text
- View/download PDF
3. Pseudomonas aeruginosa lasR mutants are associated with cystic fibrosis lung disease progression
- Author
-
Bonnie W. Ramsey, Laura S. Houston, Samuel I. Miller, Lucas R. Hoffman, Julia Emerson, Hemantha D. Kulasekara, and Jane L. Burns
- Subjects
Male ,Pulmonary and Respiratory Medicine ,Mucoidy ,Mutant ,medicine.disease_cause ,Cystic fibrosis ,Article ,Microbiology ,03 medical and health sciences ,Bacterial Proteins ,medicine ,Transcriptional regulation ,Humans ,Pseudomonas Infections ,Pediatrics, Perinatology, and Child Health ,Child ,Retrospective Studies ,030304 developmental biology ,0303 health sciences ,Mutation ,030306 microbiology ,Pseudomonas aeruginosa ,business.industry ,Age Factors ,Sputum ,biochemical phenomena, metabolism, and nutrition ,respiratory system ,medicine.disease ,bacterial infections and mycoses ,Phenotype ,Lung function ,3. Good health ,Cross-Sectional Studies ,Lung disease ,Pediatrics, Perinatology and Child Health ,Immunology ,Disease Progression ,Trans-Activators ,Female ,lasR ,medicine.symptom ,business - Abstract
BackgroundPseudomonas aeruginosa with mutations in the transcriptional regulator LasR chronically infect the airways of people with cystic fibrosis (CF), yet the prevalence and clinical implications of lasR mutant infection are unknown.MethodsIn an exploratory study, we screened 166 P. aeruginosa isolates from 58 CF patients for LasR inactivation and mucoidy, and compared clinical characteristics among source patients.ResultslasR mutation prevalence was comparable to that of mucoidy, the best-described CF-adapted phenotype, but affected patients were on average approximately 2 years younger. In a regression analysis, lung function decline with age was worse among patients with lasR mutant infection than in those without, similar to the effect of mucoidy.ConclusionsCulture positivity for lasR mutant P. aeruginosa may serve as a marker of early CF adaptive change of prognostic significance. Furthermore, as LasR inactivation alters susceptibility to antibiotics, infection with lasR mutant P. aeruginosa may impact response to therapy.
- Full Text
- View/download PDF
4. Does bacterial density in cystic fibrosis sputum increase prior to pulmonary exacerbation?
- Author
-
Franziska A. Stressmann, Mary P. Carroll, Peter Marsh, Collette Allen, Graeme Jones, Andrew K. Lilley, Nilesh Patel, Geraint B. Rogers, Kenneth D. Bruce, T. Daniels, Andrew Tuck, Lucas R. Hoffman, and Benjamin John Forbes
- Subjects
Adult ,Male ,Pulmonary and Respiratory Medicine ,medicine.medical_specialty ,Adolescent ,Cystic Fibrosis ,Real-Time Polymerase Chain Reaction ,medicine.disease_cause ,Severity of Illness Index ,Cystic fibrosis ,Gastroenterology ,Young Adult ,Internal medicine ,Severity of illness ,Pneumonia, Bacterial ,medicine ,Humans ,Pseudomonas Infections ,Clinical significance ,Pediatrics, Perinatology, and Child Health ,Respiratory system ,Young adult ,business.industry ,Pseudomonas aeruginosa ,Sputum ,Bacterial enumeration infection molecular respiratory ,Middle Aged ,medicine.disease ,Bacterial Load ,Anti-Bacterial Agents ,Respiratory Function Tests ,Pneumonia ,Pediatrics, Perinatology and Child Health ,Immunology ,Female ,medicine.symptom ,business - Abstract
Background Cystic Fibrosis (CF) lung disease is characterised by an inexorable decline in lung function, punctuated by periods of symptomatic worsening known as pulmonary exacerbations (referred to here as CFPE). Despite their clinical significance, the cause of CFPE remains undetermined. It has been suggested that an increase in bacterial density may be a trigger, although this has not been shown empirically. Methods Here, a previously validated quantitative PCR-based approach was used to assess numbers of Pseudomonas aeruginosa and of total bacteria in respiratory secretions from patients during the period leading up to CFPE. Sputum samples collected from 12 adult CF patients were selected retrospectively to fall approximately 21, 14, 7 and 0days prior to CFPE diagnosis. In addition, the relationships between clinical parameters (FEV 1 , temperature and patient reported outcome measures) and microbiological data were investigated. Results No significant changes either in total bacterial or P . aeruginosa numbers were identified prior to CFPE. Of all the correlations tested, only temperature showed a significant correlation with total bacterial numbers in the period leading to CFPE. Conclusions These findings strongly suggest that CFPE do not generally result from increased bacterial density within the airways. Instead, data presented here are consistent with alternative models of pulmonary exacerbation.
- Full Text
- View/download PDF
5. Does bacterial density in cystic fibrosis sputum increase prior to pulmonary exacerbation?
- Author
-
Stressmann, Franziska A., Rogers, Geraint B., Marsh, Peter, Lilley, Andrew K., Daniels, Thomas W.V., Carroll, Mary P., Hoffman, Lucas R., Jones, Graeme, Allen, Collette E., Patel, Nilesh, Forbes, Benjamin, Tuck, Andrew, and Bruce, Kenneth D.
- Subjects
- *
CYSTIC fibrosis , *DISEASE exacerbation , *PULMONARY function tests , *POLYMERASE chain reaction , *PSEUDOMONAS aeruginosa , *MOLECULAR microbiology - Abstract
Abstract: Background: Cystic Fibrosis (CF) lung disease is characterised by an inexorable decline in lung function, punctuated by periods of symptomatic worsening known as pulmonary exacerbations (referred to here as CFPE). Despite their clinical significance, the cause of CFPE remains undetermined. It has been suggested that an increase in bacterial density may be a trigger, although this has not been shown empirically. Methods: Here, a previously validated quantitative PCR-based approach was used to assess numbers of Pseudomonas aeruginosa and of total bacteria in respiratory secretions from patients during the period leading up to CFPE. Sputum samples collected from 12 adult CF patients were selected retrospectively to fall approximately 21, 14, 7 and 0days prior to CFPE diagnosis. In addition, the relationships between clinical parameters (FEV1, temperature and patient reported outcome measures) and microbiological data were investigated. Results: No significant changes either in total bacterial or P. aeruginosa numbers were identified prior to CFPE. Of all the correlations tested, only temperature showed a significant correlation with total bacterial numbers in the period leading to CFPE. Conclusions: These findings strongly suggest that CFPE do not generally result from increased bacterial density within the airways. Instead, data presented here are consistent with alternative models of pulmonary exacerbation. [Copyright &y& Elsevier]
- Published
- 2011
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.